Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer

[Image: see text] Despite advances in precision medicine approaches over the past decade, the majority of nonsmall cell lung cancers (NSCLCs) are refractory to treatment with targeted small molecule inhibitors. Previous work has identified mutations in the Discoidin Domain Receptor 2 (DDR2) kinase a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:ACS Chem Biol
Huvudupphovsmän: Terai, Hideki, Tan, Li, Beauchamp, Ellen M., Hatcher, John M., Liu, Qingsong, Meyerson, Matthew, Gray, Nathanael S., Hammerman, Peter S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Chemical Society 2015
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4685943/
https://ncbi.nlm.nih.gov/pubmed/26390252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschembio.5b00655
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk